Acarix
0.29 SEK
0.00 %
Less than 1K followers
ACARIX
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Acarix
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 1.9 | 2.2 | 3.8 | 5.8 | 6.2 | 6.2 | 7.4 |
| growth-% | 16.9 % | 73.3 % | 54.8 % | 7.2 % | -0.6 % | 18.7 % | |
| EBITDA | -42.3 | -38.0 | -48.3 | 73.4 | -74.5 | -66.4 | -46.3 |
| EBIT | -46.4 | -41.4 | -51.7 | -76.5 | -77.6 | -66.4 | -48.0 |
| Profit before taxes | -46.4 | -41.5 | -51.7 | -77.0 | -77.8 | -66.2 | -48.1 |
| Net income | -46.5 | -41.5 | -51.7 | -77.0 | -77.8 | -66.2 | -48.1 |
| EPS | -1.23 | -0.39 | -0.30 | -0.28 | -0.16 | -0.07 | -0.04 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % |
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | -2,279.4 % | -1,750.1 % | -1,285.1 % | 1,261.9 % | -1,193.3 % | -1,070.5 % | -628.7 % |
| EBIT-% | -2,501.0 % | -1,909.3 % | -1,374.9 % | -1,314.1 % | -1,242.8 % | -1,070.5 % | -652.3 % |
| ROE | -60.6 % | -50.5 % | -51.5 % | -148.5 % | -150.0 % | -87.4 % | -126.0 % |
| ROI | -56.0 % | -46.1 % | -43.6 % | -110.8 % | -123.8 % | -82.0 % | -99.5 % |